Global Alzheimer's Platform Foundation

📍 Washington, United States👥 52 employees💰 Last funded Sep 2016
Hospitals and Health Care🌐 globalalzplatform.org
Website LinkedIn
The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s & Parkinson's clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s & Parkinson's disease. GAP is a standing, global, trial-ready platform to drive quality, efficiency, equity and innovation in Alzheimer’s and Parkinson's Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network of certified high-performance clinical trial sites, and an adaptive proof-of-concept trial mechanism. Connect with us on our Facebook page, @GlobalALZPlatform, and on Twitter, @GAP_Foundation, where we share updates from our GAP-Network (GAP-Net) and from the volunteers that make it all possible.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Global Alzheimer's Platform Foundation?
Global Alzheimer's Platform Foundation has 1 investors on record on gritt.io.
When did Global Alzheimer's Platform Foundation last raise funding?
The most recent investment in Global Alzheimer's Platform Foundation recorded on gritt.io was in September 2016.
What industry is Global Alzheimer's Platform Foundation in?
Global Alzheimer's Platform Foundation operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Global Alzheimer's Platform Foundation based?
Global Alzheimer's Platform Foundation is headquartered in Washington, United States.